Leaflet OPHTASONE ophthalmic drops solution

Product code:
W02233001
Quantity:
1
Indicated for:
bacterial infections
Route of administration:
ophthalmic
Substance:
gentamicin + betamethasone (aminoglycoside antibiotic + glucocorticoid)
ATC
S01CA05 — Sensory organs | Antiinflammatory agents and antiinfectives in combination | Corticosteroids and antiinfectives in combination

Precautions:

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Colitis / severe diarrhea

Seek medical advice if severe or persistent diarrhea occurs.

Hyperglycemia

This medicine may increase blood sugar.

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

The combination of gentamicin and betamethasone is used to treat skin or inflammatory infections caused by susceptible bacteria and requiring inflammation reduction. It is commonly available as creams, ointments, or drops (ophthalmic or otic), depending on the location of the condition.

- Gentamicin is an aminoglycoside antibiotic that works by inhibiting bacterial protein synthesis, providing a bactericidal effect against gram-negative and some gram-positive bacteria.
- Betamethasone is a potent corticosteroid that reduces inflammation, itching, and redness by suppressing the body's inflammatory and immune response.

This combination is indicated for conditions such as infected dermatitis, infected eczema, otitis externa, or bacterial conjunctivitis associated with severe inflammation.

Side effects may include local irritation, burning sensation, dryness, or allergic reactions. Prolonged use of corticosteroids can lead to skin thinning, stretch marks, or secondary infections. When used near the eyes, there is a risk of increased intraocular pressure or cataract development.

Patients should strictly follow their doctor’s instructions regarding the duration and method of application. It is important not to use this combination long-term or on large areas of skin without medical supervision, as it may increase the risk of systemic side effects.

General data about OPHTASONE

Substance:
gentamicin + betamethasone
Date of latest medicines list:
01-07-2013
Product code:
W02233001
Pharmaceutical form:
ophthalmic drops solution
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.